Bullock Wealth Management’s Globus Medical GMED Stock Holding History

Bullock Wealth Management’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.53K	Buy	+86	New	+$7.31K	﹤0.01%	485

Other funds holding GMED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Bullock Wealth Management's GMED Position: Q2 2026 in Review

Bullock Wealth Management opened a new position in Globus Medical (GMED) in Q2 2026: 86 shares worth $6.53K. The stake represents ﹤0.01% of the portfolio and ranks #485 among its holdings.

593 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

Bullock Wealth Management held 86 shares of Globus Medical worth $6.53K as of Q2 2026.
Globus Medical was a new Bullock Wealth Management position in Q2 2026.
Globus Medical made up ﹤0.01% of Bullock Wealth Management's portfolio in Q2 2026, its #485 holding.
593 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Bullock Wealth Management's 13F filing for Q2 2026, filed 19 Aug 2026.